Nabrosov Nabrosov

Spearheaded the independent development of multiple novel drug directions, including non-narcotic anticancer cannabinoids and mild dopaminergic drugs, yielding dozens of promising drug candidates.

Conducted in-depth preclinical research into physiologically active alcohols, synthetic terpenes, and light cannabinoids, identifying new therapeutic approaches and drug design strategies.

Executed self-administered trials of proprietary substances, demonstrating profound commitment to understanding pharmacological effects and informing subsequent research directions.

Designed comprehensive new drug projects, encompassing drug design, data analysis, and trial methodologies, with a substantial portfolio ready for advanced laboratory and vivarium research.

Contributed as a Synthetic Organic Chemist to cutting-edge biomolecular research, synthesizing complex organic compounds for drug discovery initiatives.

Applied advanced synthetic methodologies to support projects focused on novel therapeutic agents and understanding biological interactions.

Collaborated on interdisciplinary research efforts, providing critical chemical expertise to accelerate biomolecular investigations.

Performed intricate organic synthesis for a leading chemical solutions provider, delivering custom compounds and intermediates for diverse research and development projects.

Optimized synthetic routes and reaction conditions to enhance efficiency and yield in the production of specialized chemical entities.

Supported external clients and internal R&D by providing high-quality chemical synthesis, contributing to a broad range of drug discovery and materials science applications.